Epsilon M&A Deal Report - Trinity Biotech's Coagulation Business
Transaction Multiples for the Valuation of Private Companies
Diagnostica Stago (Stago Group) / Trinity Biotech's Coagulation Business
No EMAT :
21107
Announced Date :
11/03/2010
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Diagnostica Stago (Stago Group)
Target :
Trinity Biotech's Coagulation Business
Country :
Ireland
Sector of activity :
- Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Supplies
Business Description :
The Coagulation Business of Trinity Biotech manufactures test kits and instrumentation used in the detection of blood coagulation and clotting disorders . > The product offering is marketed globally...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Supplies » = 73
| Date | Acquirer | Target | Country | Multiples | See details |
| 12/01/2010 | Qiagen | ESE (QIAGEN Lake Constance GmbH) | Germany | * | 21075 |
| 15/11/2005 | Allergan | Inamed | United States | * | 21070 |
Source: Epsilon Research / EMAT
